Erratum: Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression (International Journal of Oncology (2014) 45 (1059-1064) DOI: 10.3892/ijo.2014.2507);Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression

International Journal of Oncology

Volumn 45, Issue 3, 2014, Pages 1059-1064

  Uraki, Satoko ^a   Sugimoto, Kazushi ^a   Shiraki, Katsuya ^a   Tameda, Masahiko ^a   Inagaki, Yuji ^a   Ogura, Suguru ^a   Kasai, Chika ^a   Nojiri, Keiichiro ^a   Yoneda, Misao ^a   Yamamoto, Norihiko ^a   Takei, Yoshiyuki ^a   Nobori, Tsutomu ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell migration; Colon cancer; Human defensin 3; MTA2

Indexed keywords

BETA DEFENSIN 3; MESSENGER RNA; METASTASIS ASSOCIATED 1 FAMILY MEMBER 2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BETA DEFENSIN; BETA-DEFENSIN 3, HUMAN; HISTONE DEACETYLASE; MTA2 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS INHIBITION; MIGRATION INHIBITION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL PROLIFERATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BETA-DEFENSINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HT29 CELLS; HUMANS; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; REPRESSOR PROTEINS; RNA, MESSENGER;

EID: 84904396766     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2868     Document Type: Erratum

References (43)

1. Raj PA and Dentino AR: Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 206: 9-18, 2002. (Pubitemid 34084931)
2. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720, 2003.
3. Yang D, Biragyn A, Hoover DM, Lubkowski J and Oppenheim JJ: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22: 181-215, 2004. (Pubitemid 38680422)
4. Schutte BC, Mitros JP, Bartlett JA, et al: Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 99: 2129-2133, 2002. (Pubitemid 34169026)
5. Jia HP, Schutte BC, Schudy A, et al: Discovery of new human beta-defensins using a genomics-based approach. Gene 263: 211-218, 2001. (Pubitemid 32167071)
6. Sorensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA and Ganz T: Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 174: 4870-4879, 2005.
7. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000. (Pubitemid 30398626)
8. Wu Z, Hoover DM, Yang D, et al: Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci USA 100: 8880-8885, 2003. (Pubitemid 36899192)
9. Shestakova T, Zhuravel E, Bolgova L, Alekseenko O, Soldatkina M and Pogrebnoy P: Expression of human beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: a pilot study. Exp Oncol 30: 153-156, 2008. (Pubitemid 351951394)
10. Shestakova T, Zhuravel E, Bolgova L, et al: Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors. Exp Oncol 32: 273-276, 2010.
11. Arimura Y, Ashitani J, Yanagi S, et al: Elevated serum beta-defensins concentrations in patients with lung cancer. Anticancer Res 24: 4051-4057, 2004. (Pubitemid 40468706)
12. Markeeva N, Lisovskiy I, Lyzogubov V, et al: Expression of beta-defensin-2 in human gastric tumors: a pilot study. Exp Oncol 27: 130-135, 2005. (Pubitemid 41025735)
13. Markeeva N, Lysovskiy I, Zhuravel E, et al: Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix. Exp Oncol 27: 308-313, 2005. (Pubitemid 43139363)
14. Mburu YK, Abe K, Ferris LK, Sarkar SN and Ferris RL: Human beta-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 32: 168-174, 2010.
15. Melle C, Ernst G, Schimmel B, et al: Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 129: 66-73, 2005. (Pubitemid 41002043)
16. Albrethsen J, Bogebo R, Gammeltoft S, Olsen J, Winther B and Raskov H: Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 5: 8, 2005.
17. Albrethsen J, Moller CH, Olsen J, Raskov H and Gammeltoft S: Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. Eur J Cancer 42: 3057-3064, 2006. (Pubitemid 44679822)
18. Wang K, Wang JH, Baskaran H, Wang R and Jurevic R: Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabricated cell islands. Head Neck Oncol 4: 41, 2012.
19. Kawsar HI, Weinberg A, Hirsch SA, et al: Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol 45: 696-702, 2009.
20. Winter J, Pantelis A, Reich R, et al: Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Invest 29: 196-201, 2011.
21. Harder J, Bartels J, Christophers E and Schroder JM: Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276: 5707-5713, 2001.
22. Kawauchi K, Yagihashi A, Tsuji N, et al: Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues. World J Gastroenterol 12: 5793-5797, 2006. (Pubitemid 44594246)
23. Fahlgren A, Hammarstrom S, Danielsson A and Hammarstrom ML: beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 137: 379-385, 2004. (Pubitemid 39013085)
24. Donald CD, Sun CQ, Lim SD, et al: Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 83: 501-505, 2003. (Pubitemid 36457704)
25. Young AN, de Oliveira Salles PG, Lim SD, et al: Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 27: 199-205, 2003. (Pubitemid 36152229)
26. Bullard RS, Gibson W, Bose SK, et al: Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Mol Immunol 45: 839-848, 2008. (Pubitemid 47505263)
27. Joly S, Compton LM, Pujol C, Kurago ZB and Guthmiller JM: Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 24: 353-360, 2009.
28. Yoshimoto T, Yamaai T, Mizukawa N, et al: Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 23: 4629-4633, 2003. (Pubitemid 38173877)
29. Shuyi Y, Feng W, Jing T, et al: Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112: 616-625, 2011.
30. Xu N, Wang YS, Pan WB, et al: Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice. Mol Cancer Ther 7: 1588-1597, 2008.
31. Toh Y, Oki E, Oda S, et al: Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74: 459-463, 1997. (Pubitemid 27400170)
32. Martin MD, Fischbach K, Osborne CK, Mohsin SK, Allred DC and O'Connell P: Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene. Cancer Res 61: 3578-3580, 2001. (Pubitemid 32694964)
33. Hamatsu T, Rikimaru T, Yamashita Y, et al: The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep 10: 599-604, 2003.
34. Sasaki H, Moriyama S, Nakashima Y, et al: Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 35: 149-154, 2002. (Pubitemid 34136092)
35. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935, 1999. (Pubitemid 29407360)
36. Toh Y and Nicolson GL: The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227, 2009.
37. Ji Y, Zhang P, Lu Y and Ma D: Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication. J Huazhong Univ Sci Technolog Med Sci 26: 359-362, 2006.
38. Lee H, Ryu SH, Hong SS, et al: Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation. J Gastroenterol Hepatol 24: 1445-1450, 2009.
39. Liu SL, Han Y, Zhang Y, et al: Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer. Target Oncol 7: 135-143, 2012.
40. Covington KR, Brusco L, Barone I, et al: Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer. Breast Cancer Res Treat 141: 375-384, 2013.
41. Zhou C, Ji J, Cai Q, et al: MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1. Mol Cancer 12: 102, 2013.
42. Cui Y, Niu A, Pestell R, et al: Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20: 2020-2035, 2006. (Pubitemid 44286702)
43. Luo J, Su F, Chen D, Shiloh A and Gu W: Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381, 2000.